Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PSF, CFG

Statement from the Chief Public Health Officer of Canada on June 30, 2020


OTTAWA, ON, June 30, 2020 /CNW/ - In lieu of an in-person update to the media, Dr. Theresa Tam, Canada's Chief Public Health Officer, issued the following statement today:

"There have been 103,918 cases, including 8,566 deaths. 65% of people have now recovered. Labs across Canada have tested over 2,721,685 people for COVID-19 to date. Over the past week, an average of 37,000 people were tested daily, with 1% testing positive. These numbers change quickly and are updated daily in the evenings on Canada.ca/coronavirus.

Although cases of COVID-19 continue to decline in Canada, the increasing number of infections in many other countries is a reminder of how quickly things can change, and how quickly this virus can spread.

As Canadians continue to live with the reality of a global pandemic, we must all remain vigilant. By observing public health measures and avoiding exposure risks, we can keep COVID-19 under control. This includes:

Because COVID-19 activity and precautions are not the same everywhere in the country, be sure to also consult with and follow the advice of the local public health authority where you live.

As we are all aware, our seniors and others at high risk for COVID-19 severe outcomes have been hardest hit during this crisis. We all have a responsibility to do everything in our power to protect those most at risk from the virus. We can't prevent every death but we must prevent every death we can."

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 08:10
bioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today announced David Elzi, Ph.D., has been named Vice President of...

at 08:10
Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced the availability of Over the Counter ("OTC") Naloxone Hydrochloride (Naloxone HCI) Nasal Spray, USP, 4mg, following Abbreviated New Drug Application ("ANDA") approval from the...

at 08:10
BigHat Biosciences, a biotechnology company with an artificial intelligence/machine learning-guided antibody discovery and development platform announced a collaboration with Janssen Biotech Inc., a Johnson & Johnson company. This strategic...

at 08:10
Kiromic BioPharma, Inc. ("Kiromic" or the "Company") announces consistent favorable safety, tolerability, and efficacy from follow-up visits of the first cohort of three patients enrolled in the Company's Deltacel-01 Phase 1 clinical trial....

at 08:05
The Board of Directors of McKesson Corporation yesterday declared a regular dividend of 62 cents per share of common stock. The dividend will be payable on July 1, 2024, to stockholders of record on June 3, 2024. About McKesson Corporation...

at 08:05
symplr®, a leading provider of enterprise healthcare operations software, today announced a new partnership integrating award-winning healthcare worker payments technology from Branch, a workforce payments platform. With the integrated pay solution,...



News published on and distributed by: